October 5, 2020
PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2
PT150 is a clinical stage molecule, taken orally, with a strong safety profile having completed Phase 1 and Phase 2 clinical trials for its original use as an antidepressant. It has an active IND for COVID-19. Antiviral activities have been... Read More